Viz HCM vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Volta Medical

AI Verdict

Tool A, Viz HCM, is designed for the early detection and care coordination of Hypertrophic Cardiomyopathy through real-time ECG analysis. In contrast, Tool B, VX1+, provides AI-driven assistance to electrophysiologists during cardiac ablation procedures for atrial fibrillation and tachycardia. While both are cardiology AI tools, they address different clinical problems and stages of patient care, making them adjacent rather than direct competitors.

Choose Viz HCM if…

Choose Viz HCM if your primary objective is to enhance early detection and streamline the care pathway for Hypertrophic Cardiomyopathy (HCM) across your health system. This AI tool leverages real-time ECG analysis to identify suspected HCM cases and then automates the coordination of multidisciplinary care, significantly reducing diagnosis time and improving patient flow.

View Viz HCM →

Choose VX1+ if…

Choose VX1+ if your electrophysiology lab aims to improve the precision and effectiveness of cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This AI-powered software provides real-time identification and annotation of abnormal electrograms during the ablation procedure, offering critical insights to assist electrophysiologists in targeting and performing more successful ablations.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz HCM VX1+
Deployment Unknown Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Tool A emphasizes mobile-based alerts and seamless integration with existing hospital IT systems like EHR and PACS, suggesting broader accessibility and easier adoption across a multidisciplinary care team. Tool B, while having a simple user interface, is more specialized for electrophysiologists during specific procedures.

Clinical Value

Viz HCM

Tool A explicitly states it significantly reduces diagnosis time for HCM and is clinically validated with extensive real-world evidence. In contrast, FDA documents for Tool B explicitly state that the clinical significance of utilizing the software to help identify areas for catheter ablation 'has not been established by clinical investigations', which is a critical distinction in proven clinical impact.

Pricing & Value

Viz HCM

Tool A provides transparent pricing as subscription-based and, crucially, details CMS reimbursement availability with specific CPT codes and payment rates, offering a clear financial value proposition for healthcare providers. Tool B's pricing information is not publicly available, making a value assessment impossible.

Enterprise Readiness

Viz HCM

Tool A explicitly confirms HIPAA compliance, BAA availability, FDA clearance, and integration with core hospital systems (EHR, PACS). Its comprehensive Trust Center also provides access to various security and compliance documentation, demonstrating strong enterprise readiness. Tool B's compliance statements are less explicit in the provided data.

Innovation

Tie

Both tools demonstrate significant innovation by applying AI to complex cardiology challenges in real-time. Tool A innovates in early disease detection and automated care coordination for a chronic condition, while Tool B innovates in real-time procedural guidance during a complex interventional procedure.

Support & Docs

Viz HCM

Viz HCM offers a more robust and comprehensive support structure, including 24/7 urgent phone support, email support, a help center, customer resources, user guides, a 'Viz Academy' for training, and dedicated customer success teams. VX1+ mentions a user manual but lacks comparable details regarding extensive support offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz HCM VX1+
Name Viz HCM VX1+
Company Viz.ai Volta Medical
Description Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Key Specialties Cardiology, Emergency Medicine, Hospital Medicine Cardiology
Primary Use Case AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection and care coordination Real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia

Videos

Demos, reviews, and walkthroughs featuring Viz HCM and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz HCM is designed for the real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) using ECG analysis and for coordinating cardiac care. In contrast, VX1+ assists electrophysiologists in the real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Viz HCM is a cloud-based platform that integrates with hospital IT systems, including Electronic Health Records (EHR) and Picture Archiving and Communication Systems (PACS), to streamline cardiac care coordination and clinical workflows. VX1+ is a software application that integrates with existing electrophysiology (EP) recording and 3D mapping systems, and is compatible with various 510(k)-cleared catheters and specific data acquisition systems.
Viz HCM has established CMS reimbursement available for Category III CPT codes 0764T and 0765T, with a national payment rate of $128.90, effective January 1, 2025. The pricing details for VX1+ are not publicly available, and there is no explicit mention of specific reimbursement codes or rates.
Viz HCM performs AI-powered analysis of real-time 12-lead electrocardiograms (ECGs) to detect patterns suggestive of Hypertrophic Cardiomyopathy. VX1+ analyzes electrograms from cardiac mapping systems to identify spatio-temporal dispersed electrograms (DEs) during atrial fibrillation and atrial tachycardia procedures.
Viz HCM is designed to support Cardiology, Emergency Medicine, and Hospital Medicine, aiming to improve early detection and care coordination for HCM across these specialties. VX1+ is specifically tailored to assist electrophysiologists within Cardiology during cardiac ablation procedures.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.